OnKure Therapeutics, Inc.

NasdaqGM:OKUR Stock Report

Market Cap: US$169.3m

OnKure Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:OKUR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
31 Mar 26BuyUS$16,593,078Leonard BlavatnikIndividual3,998,332US$4.15
23 Mar 26SellUS$357Nicholas SaccomanoIndividual86US$4.16
23 Mar 26SellUS$1,251Jason LeveroneIndividual301US$4.16
22 Dec 25SellUS$258Nicholas SaccomanoIndividual87US$2.97
22 Dec 25SellUS$896Jason LeveroneIndividual302US$2.97
22 Sep 25SellUS$231Nicholas SaccomanoIndividual88US$2.62
22 Sep 25SellUS$795Jason LeveroneIndividual303US$2.62
23 Jun 25SellUS$210Nicholas SaccomanoIndividual88US$2.38
23 Jun 25SellUS$722Jason LeveroneIndividual303US$2.38

Insider Trading Volume

Insider Buying: OKUR insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of OKUR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders4,260,69110.5%
General Public4,731,90411.7%
Hedge Funds9,133,86822.6%
VC/PE Firms9,498,61923.5%
Institutions12,770,39831.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 199%.

Top Shareholders

Top 25 shareholders own 84.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.9%
RA Capital Management, L.P.
3,998,333US$16.8m0%0.23%
9.9%
Leonard Blavatnik
3,998,332US$16.8m0%no data
7.03%
Acorn Bioventures
2,839,674US$11.9m0%4.14%
6.59%
StepStone Group Inc.
2,660,612US$11.1m441%3.03%
6.03%
ADAR1 Capital Management, LLC
2,434,941US$10.2m140%0.64%
5.97%
Trails Edge Capital Partners, LP
2,409,638US$10.1m0%2.27%
5.33%
Prosight Management, LP
2,154,381US$9.0m164%1.67%
5.29%
BVF Partners L.P.
2,134,908US$8.9m7.88%0.26%
4.77%
Vivo Capital, LLC
1,927,710US$8.1m0%0.75%
4.55%
Vestal Point Capital, LP
1,839,819US$7.7m190%0.22%
3.58%
Foresite Capital Management, LLC
1,445,783US$6.1m0%0.61%
2.98%
Adage Capital Management, L.P.
1,204,819US$5.0m0%0.01%
2.67%
Sio Capital Management, LLC
1,078,965US$4.5m0%0.65%
1.44%
Vanguard Capital Management, LLC
582,477US$2.4m0%no data
1.18%
New Enterprise Associates, Inc.
478,548US$2.0m0%0.15%
1.1%
Rosalind Advisors, Inc.
443,763US$1.9m-39.3%0.79%
0.93%
Renaissance Technologies LLC
377,250US$1.6m52.5%no data
0.86%
BML Capital Management, LLC
345,739US$1.4m0%0.86%
0.73%
Spearhead Insurance Solutions Idf, Llc
295,020US$1.2m0%11.13%
0.67%
Abingworth LLP
269,895US$1.1m0%1.0%
0.6%
Dv Trading, LLC
240,963US$1.0m0%0.09%
0.6%
Affinity Asset Advisors, LLC
240,963US$1.0m0%0.07%
0.56%
Octagon Capital Advisors LP
225,000US$942.7k0%0.1%
0.5%
Lundbeckfonden BioCapital
203,122US$851.1k0%0.01%
0.49%
RiverVest Venture Management LLC
196,198US$822.1k0%52.19%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/11 07:30
End of Day Share Price 2026/06/11 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

OnKure Therapeutics, Inc. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert BurnsH.C. Wainwright & Co.
Soumit RoyJonesTrading Institutional Services, LLC
Andrew BerensLeerink Partners LLC